HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zafar Zafari Selected Research

enadoline

6/2022Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zafar Zafari Research Topics

Disease

10Asthma (Bronchial Asthma)
06/2022 - 10/2014
6Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 03/2014
2Neoplasms (Cancer)
06/2022 - 01/2022
2Macular Degeneration (Age-Related Maculopathy)
02/2019 - 01/2018
1Heart Failure
06/2022
1Infections
05/2022
1Pneumonia (Pneumonitis)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Medulloblastoma
01/2017
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2015

Drug/Important Bio-Agent (IBA)

3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 03/2015
2Omalizumab (Xolair)FDA Link
01/2018 - 01/2016
1Bronchodilator Agents (Bronchodilators)IBA
06/2022
1LipidsIBA
06/2022
1enadolineIBA
06/2022
1AerosolsIBA
05/2022
1Dihydrotachysterol (AT 10)IBA
01/2022
1SmokeIBA
01/2022
1Methacholine Chloride (Methacholine)FDA Link
01/2020
1afliberceptIBA
02/2019
1antineoplaston A10 (A 10)IBA
01/2018
1Tiotropium Bromide (Spiriva)FDA Link
01/2018
1Ranibizumab (Lucentis)FDA Link
01/2018
1Azithromycin (Zithromax)FDA LinkGeneric
11/2016
1Rosiglitazone (Avandia)FDA Link
03/2015
1Pioglitazone (Actos)FDA Link
03/2015
1Pharmaceutical PreparationsIBA
03/2015

Therapy/Procedure

7Therapeutics
01/2022 - 10/2014
4Drug Therapy (Chemotherapy)
01/2017 - 03/2014
1Length of Stay
01/2022
1Nebulizers and Vaporizers (Inhaler)
12/2021
1Precision Medicine
01/2019
1Bronchial Thermoplasty
01/2016